Kathleen D. Scott - Net Worth and Insider Trading
Kathleen D. Scott Net Worth
The estimated net worth of Kathleen D. Scott is at least $142,417 dollars as of 2024-12-27. Kathleen D. Scott is the CFO of ARS Pharmaceuticals Inc and owns about 13,199 shares of ARS Pharmaceuticals Inc (SPRY) stock worth over $142,417. Details can be seen in Kathleen D. Scott's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kathleen D. Scott has not made any transactions after 2024-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kathleen D. Scott
Kathleen D. Scott Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kathleen D. Scott owns 5 companies in total, including Histogen Inc (HSTOQ) , Dermata Therapeutics Inc (DRMA) , and Silverback Therapeutics Inc (SBTX) among others .
Click here to see the complete history of Kathleen D. Scott’s form 4 insider trades.
Insider Ownership Summary of Kathleen D. Scott
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HSTOQ | Histogen Inc | 2019-11-18 | director |
DRMA | Dermata Therapeutics Inc | 2021-08-12 | director |
SBTX | Silverback Therapeutics Inc | 2022-11-08 | Chief Financial Officer |
2024-10-16 | Chief Financial Officer | ||
2023-09-29 | director |
Kathleen D. Scott Latest Holdings Summary
Kathleen D. Scott currently owns a total of 1 stock. Kathleen D. Scott owns 13,199 shares of ARS Pharmaceuticals Inc (SPRY) as of October 16, 2024, with a value of $142,417.
Latest Holdings of Kathleen D. Scott
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SPRY | ARS Pharmaceuticals Inc | 2024-10-16 | 13,199 | 10.79 | 142,417 |
Holding Weightings of Kathleen D. Scott
Kathleen D. Scott Form 4 Trading Tracker
According to the SEC Form 4 filings, Kathleen D. Scott has made a total of 3 transactions in ARS Pharmaceuticals Inc (SPRY) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in ARS Pharmaceuticals Inc is the sale of 12,500 shares on October 16, 2024, which brought Kathleen D. Scott around $200,000.
Insider Trading History of Kathleen D. Scott
- 1
Kathleen D. Scott Trading Performance
GuruFocus tracks the stock performance after each of Kathleen D. Scott's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kathleen D. Scott is 50.17%. GuruFocus also compares Kathleen D. Scott's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kathleen D. Scott within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kathleen D. Scott's insider trading performs compared to the benchmark.
Performance of Kathleen D. Scott
Kathleen D. Scott Ownership Network
Kathleen D. Scott Owned Company Details
What does Histogen Inc do?
Who are the key executives at Histogen Inc?
Kathleen D. Scott is the director of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .
Histogen Inc (HSTOQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Histogen Inc (HSTOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Histogen Inc Insider Transactions
Kathleen D. Scott Mailing Address
Above is the net worth, insider trading, and ownership report for Kathleen D. Scott. You might contact Kathleen D. Scott via mailing address: C/o Conatus Pharmaceuticals Inc., 16745 West Bernardo Drive, Suite 200, San Diego Ca 92127.